Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA1 | P30542 | 1/20 | 0.46 |
| ▸ | GCGR | P47871 | 18/20 | 0.43 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16429685 | 0.87 | GCGR (0.57) | ADORA1GCGRSCN9A | |
| SCHEMBL2344474 | 0.83 | ADORA1 (0.48) | ADORA1GCGRSCN9A | |
| SCHEMBL526597 | 0.83 | GCGR (0.45) | ADORA1GCGRSCN9A | |
| SCHEMBL3264910 | 0.82 | GCGR (0.41) | GCGR | |
| SCHEMBL4452687 | 0.81 | GCGR (0.46) | GCGR | |
| SCHEMBL527760 | 0.81 | ADORA1 (0.49) | ADORA1GCGRSCN9A | |
| SCHEMBL16429686 | 0.81 | GCGR (0.49) | GCGR | |
| SCHEMBL2340032 | 0.80 | ADORA1 (0.48) | ADORA1GCGRSCN9A | |
| SCHEMBL2340089 | 0.80 | ADORA1 (0.48) | ADORA1GCGRSCN9A | |
| SCHEMBL4455298 | 0.80 | GCGR (0.48) | GCGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2598484-B1 | PROCESS FOR THE PREPARATION OF KEY INTERMEDIATES FOR THE SYNTHESIS OF STATINS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF | LEK PHARMACEUTICALS (SI) | 2016-06-29 | — | — | EP | disclosed |
| EP-2391609-B1 | KEY INTERMEDIATES FOR THE SYNTHESIS OF ROSUVASTATIN OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF | LEK PHARMACEUTICALS (SI) | 2015-01-28 | — | — | EP | disclosed |
| WO-2010086438-A1 | KEY INTERMEDIATES FOR THE SYNTHESIS OF ROSUVASTATIN OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF | LEK PHARMACEUTICALS D.D. (SI) | 2010-08-05 | — | — | WO | disclosed |